Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2/3 1

Status

Unknown 3

Sponsor Class

OTHER 178INDUSTRY 86NIH 17OTHER_GOV 3NETWORK 3UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Head & Neck 1

Conditions

Carcinoma, Hepatocellular 3Neoplasms 1Liver Neoplasms 1Carcinoma 1

Interventions

Oxaliplatin 30Capecitabine 26Fluorouracil 20Irinotecan 19tislelizumab 18apatinib 16Paclitaxel 13Cisplatin 13S 1 (combination) 12Radiotherapy 12Leucovorin 11Bevacizumab 11Laparoscopy 9Drug Therapy 9Cetuximab 9sintilimab 8Endoscopic Mucosal Resection 8Radiation 7Gemcitabine 7Docetaxel 7camrelizumab 6XELOX 6Surgical Procedures, Operative 6Propranolol 6Nivolumab 6Neoadjuvant Therapy 6Immune Checkpoint Inhibitors 6Folfox protocol 6Levoleucovorin 5HMPL-013 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Sorafenib × Gastrointestinal × Clear all
NCT05391867 2022-05-26

Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma

Sir Salimullah Medical College Mitford Hospital

Phase NA Unknown
70 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02794337 2022-04-27

TACE-SBRT

Tata Memorial Hospital

Phase 2/3 Unknown
67 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01214343 2011-06-15

Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC

Ministry of Health, Labour and Welfare, Japan

Phase 3 Unknown
190 enrolled
Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡